Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Netherlands

 

Orpea selling 32 Dutch nursing homes and paying back €55.8m to French government

Orpea is selling 32 of its nursing homes in The Netherlands to Syntrus Achmea Real Estate & Finance (a REIT) for approximately €125m, as part of the asset disposal part of its plan to clean up its finances. The company, which is also trying to clean up its reputation in light of accusations of malpractice, has agreed to pay back €55.8m to the French government after public investigations following the suggestion it misappropriated public funds.

European Dental Group “up for sale soon”

HBI hears that pan-European and dentist-led European Dental Group (EDG) could be up for sale soon. HBI takes a look at the business and possible pricing at a time when dentistry continues to be a hot ticket.

Why Westminster NHS systems fail

Profound pessimism about NHS plans for integrated health and with NHS systems in the UK and Canada was on display from academics at the European Health Policymakers Group which celebrated its 21st year in an afternoon looking at what the group had learnt studying Beveridge (NHS) and Bismarckian (statutory insurer) models.

Dutch government looks to pull funding from nursing homes

Dutch elderly care is seeing a very definite government-backed shift away from nursing homes and towards care at home, with increasing reluctance for the public purse to pay for the 'hotel' component of care. HBI speaks to advisor Rune Aresvik from Vardetun, who has just completed a detailed review of the sector, to find out if this is a problem or an opportunity

Affidea deal – underbidders and EBITDA

HBI hears that the surprise buyer of European imaging and cancer treatment provider Affidea, Groupe Bruxelles Lambert (GBL) may not have been the highest bidder, despite winning out. HBI considers who else was in the running, and the EBITDA figure that may have been used for the deal.

Affidea bought by Groupe Bruxelles Lambert

Groupe Bruxelles Lambert (“GBL”) has signed definitive agreements to acquire a majority stake in European imaging and cancer treatment provider Affidea from B-FLEXION, the private investment firm of the Switzerland-based billionaire Bertarelli family. GBL will invest up to €1bn of equity for the transaction which is its first substantive healthcare investment.

Residential care costs of dementia care soar

Alzheimer’s is one of the world’s most expensive diseases, costing around $1 trillion per year globally, research estimates. As cases are forecast to triple by 2050, this figure is only going to increase. To make matters worse, new research suggests that the per-person cost of treatment is also growing.

New Dutch cabinet looks to shift elderly out of care homes

Elections in the Netherlands last year saw Mark Rutte, the Liberal prime minister, return for a fourth term, and belatedly we now have a new cabinet. Could we see a new direction for healthcare following this new mandate?

Find Us